{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:51:08Z","timestamp":1793019068847,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jinf.2012.05.001","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T20:00:57Z","timestamp":1336593657000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: How firm is the Aspergillus diagnosis?"],"prefix":"10.1016","volume":"65","author":[{"given":"Sarah P.","family":"Georgiadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2012.05.001_bib1","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989\u20132003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2012.05.001_bib2","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/313445","article-title":"Aspergillosis in children with cancer: a 34-year experience","volume":"29","author":"Abbasi","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/597400","article-title":"Phaeohyphomycosis in a tertiary care cancer center","volume":"48","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00134-011-2344-8","article-title":"Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis","volume":"37","author":"Burghi","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2012.05.001_bib5","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2012.05.001_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jinf.2010.01.010","article-title":"Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998\u20132009","volume":"60","author":"Campo","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2012.05.001_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1439-0507.2007.01449.x","article-title":"Invasive aspergillosis in a paediatric haematology department: a 15-year review","volume":"51","author":"Crassard","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.jinf.2012.05.001_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF01690991","article-title":"An autopsy study of systemic fungal infections in patients with hematologic malignancies","volume":"14","author":"Jandrlic","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib11","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib12","series-title":"Medically important fungi","author":"Larone","year":"2002"},{"key":"10.1016\/j.jinf.2012.05.001_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/518873","article-title":"Polymicrobial infection in patients with cancer: an underappreciated and underreported entity","volume":"45","author":"Rolston","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/342061","article-title":"Aspergillosis: the most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease","volume":"35","author":"Alangaden","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MD.0b013e3181779b53","article-title":"Legionella pneumonia in cancer patients","volume":"87","author":"Jacobson","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jinf.2012.05.001_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00005792-200209000-00004","article-title":"Nocardiosis in cancer patients","volume":"81","author":"Torres","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jinf.2012.05.001_bib17","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1001\/jama.2011.1886","article-title":"Consideration of multiple chronic diseases in randomized controlled trials","volume":"306","author":"Jadad","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2012.05.001_bib18","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","article-title":"Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial)","volume":"110","author":"Caillot","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2012.05.001_bib19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2012.05.001_bib21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/jac\/dkn401","article-title":"Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment","volume":"62","author":"Hachem","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2012.05.001_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jinf.2004.05.011","article-title":"Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study","volume":"50","author":"Kartsonis","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2012.05.001_bib23","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib24","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/cncr.25312","article-title":"Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?","volume":"116","author":"Mihu","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2012.05.001_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.leu.2405065","article-title":"Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin","volume":"22","author":"Raad","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jinf.2012.05.001_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/cncr.23311","article-title":"Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2012.05.001_bib29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/10428190500205486","article-title":"Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies","volume":"46","author":"Martino","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jinf.2012.05.001_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cir441","article-title":"Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition","volume":"53","author":"Nouer","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0609.2009.01391.x","article-title":"Diagnostic challenges and recent advances in the early management of invasive fungal infections","volume":"84","author":"Chandrasekar","year":"2010","journal-title":"Eur J Haematol"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2012.05.001_bib32","doi-asserted-by":"crossref","first-page":"i15","DOI":"10.1093\/jac\/dkq438","article-title":"Detection and investigation of invasive mould disease","volume":"66","author":"Cuenca-Estrella","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2012.05.001_bib33","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jinf.2011.08.007","article-title":"Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value","volume":"63","author":"Park","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2012.05.001_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11046-007-9010-2","article-title":"Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis","volume":"163","author":"Aquino","year":"2007","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jinf.2012.05.001_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00365541003602064","article-title":"False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics","volume":"42","author":"Boonsarngsuk","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10096-011-1244-8","article-title":"Reactivity of (1\u21923)-beta-d-glucan assay in bacterial bloodstream infections","volume":"30","author":"Albert","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1099\/jmm.0.019299-0","article-title":"Difficulties in using 1,3-{beta}-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies \u2013 high frequency of false-positive results and their analysis","volume":"59","author":"Racil","year":"2010","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jinf.2012.05.001_bib39","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1086\/588563","article-title":"Pseudomonas aeruginosa as a cause of 1,3-beta-d-glucan assay reactivity","volume":"46","author":"Mennink-Kersten","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diagmicrobio.2007.04.022","article-title":"Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay","volume":"59","author":"Cummings","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib41","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JCM.05946-11","article-title":"Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme linked immunosorbent assay","volume":"50","author":"Tortorano","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2012.05.001_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.diagmicrobio.2005.03.005","article-title":"Infectious pulmonary complications after stem cell transplantation or chemotherapy: diagnostic yield of bronchoalveolar lavage","volume":"52","author":"Bissinger","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/cid\/cir861","article-title":"Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies","volume":"54","author":"Stanzani","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib44","doi-asserted-by":"crossref","first-page":"21ra17","DOI":"10.1126\/scitranslmed.3000715","article-title":"Blood gene expression signatures predict invasive candidiasis","volume":"2","author":"Zaas","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jinf.2012.05.001_bib45","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1002\/pmic.200900768","article-title":"Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia","volume":"10","author":"Gonzales","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.jinf.2012.05.001_bib46","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/infdis\/jir050","article-title":"Are serum cytokines sensitive and specific enough to prognosticate in aspergillosis?","volume":"203","author":"Kontoyiannis","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2012.05.001_bib47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrmicro2313","article-title":"Medically important bacterial\u2013fungal interactions","volume":"8","author":"Peleg","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2012.05.001_bib48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrmicro928","article-title":"Developing animal models for polymicrobial diseases","volume":"2","author":"Bakaletz","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2012.05.001_bib49","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1128\/IAI.00012-08","article-title":"Pseudomonas aeruginosa induces localized immunosuppression during pneumonia","volume":"76","author":"Diaz","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2012.05.001_bib50","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2012.05.001_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00013-11","article-title":"Polymicrobial interactions: impact on pathogenesis and human disease","volume":"25","author":"Peters","year":"2012","journal-title":"Clin Microbiol Rev"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:17:00Z","timestamp":1759007820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0163445312001272"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.05.001","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: How firm is the Aspergillus diagnosis?","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}